Skip to main content
. Author manuscript; available in PMC: 2018 Mar 26.
Published in final edited form as: Prostate. 2016 Mar 4;76(9):796–809. doi: 10.1002/pros.23154

Fig. 2.

Fig. 2

In vitro growth curves of Ace-1 and Ace-1-huGRPr cell lines after addition of bombesin (BBN), which served as a GRPr agonist. Data presented as mean ± SD of three replicates for each cell line. Significant differences are indicated as: *P≤0.05 statistically different from control Ace-1 and Ace-1-huGRPr cells.